Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling

被引:17
作者
Dong, MQ
Liu, GM
Pinon, DI
Miller, LJ
机构
[1] Mayo Clin Scottsdale, Ctr Canc, Scottsdale, AZ 85259 USA
[2] Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA
关键词
D O I
10.1021/bi050130q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type A and B cholecystokinin (CCK) receptors are highly homologous members of the class-I family of G protein-coupled receptors that bind CCK with high affinity. However, they have divergent structural specificities, with the type A receptor requiring seven carboxyl-terminal residues including a sulfated tyrosine and the type B receptor requiring only the carboxyl-terminal tetrapeptide. The aim of this work was to utilize affinity labeling to determine spatial approximations with photolabile p-benzoyl-L-phenylalanine (Bpa) residues sited at each end of CCK as docked at the type B CCK receptor, contrasting this with analogous work using similar probes docked at the type A receptor. Both probes were fully efficacious, potent agonists that stimulated intracellular calcium in receptor-bearing CHO-CCKBR cells (EC50 values: Bpa(24) probe, 41 +/- 9 pM; Bpa(33) probe, 15 +/- 3.3 pM), They bound specifically, with high affinity (K-i values: Bpa(24) probe, 0.60 +/- 0.17 nM; Bpa(33) probe, 0.58 +/- 0.11 nM). Cyanogen bromide cleavage of the covalently labeled receptor suggested the first extracellular loop as the region of labeling by each probe, distinct from the type A CCK receptor regions labeled using the same probes (third loop and amino-terminal tail, respectively). This was confirmed by subsequent enzymatic and chemical cleavage of labeled wild-type and mutant receptors. Sequential cycles of Edman degradation of labeled receptor fragments identified the specific residues within loop one labeled by each probe (Bpa24 probe labeled Phe(122); Bpa(33) probe labeled Thr(119)). This provides a direct demonstration of distinct modes of docking the same high-affinity ligand to highly homologous receptors.
引用
收藏
页码:6693 / 6700
页数:8
相关论文
共 36 条
  • [1] Direct identification of the agonist binding site in the human brain cholecystokininB receptor
    Anders, J
    Blüggel, M
    Meyer, HE
    Kühne, R
    ter Laak, AM
    Kojro, E
    Fahrenholz, F
    [J]. BIOCHEMISTRY, 1999, 38 (19) : 6043 - 6055
  • [2] SYNTHESIS AND BINDING AFFINITIES OF CYCLIC AND RELATED LINEAR ANALOGS OF CCK8 SELECTIVE FOR CENTRAL RECEPTORS
    CHARPENTIER, B
    DOR, A
    ROY, P
    ENGLAND, P
    PHAM, H
    DURIEUX, C
    ROQUES, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (06) : 1184 - 1190
  • [3] Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth
    Cheng, ZJ
    Harikumar, KG
    Holicky, EL
    Miller, LJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52972 - 52979
  • [4] Molecular models for cholecystokinin-A receptor
    Dawson, ES
    Henne, RM
    Miller, LJ
    Lybrand, TP
    [J]. PHARMACOLOGY & TOXICOLOGY, 2002, 91 (06): : 290 - 296
  • [5] Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor
    Ding, XQ
    Pinon, DI
    Furse, KE
    Lybrand, TP
    Miller, LJ
    [J]. MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 1041 - 1052
  • [6] Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminaI probe
    Ding, XQ
    Dolu, V
    Hadac, EM
    Holicky, EL
    Pinon, DI
    Lybrand, TP
    Miller, LJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 4236 - 4244
  • [7] IDENTIFICATION AND SEQUENCE OF A BINDING-SITE PEPTIDE OF THE BETA-2-ADRENERGIC RECEPTOR
    DOHLMAN, HG
    CARON, MG
    STRADER, CD
    AMLAIKY, N
    LEFKOWITZ, RJ
    [J]. BIOCHEMISTRY, 1988, 27 (06) : 1813 - 1817
  • [8] Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling
    Dong, MQ
    Wang, Y
    Pinon, DI
    Hadac, EM
    Miller, LJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) : 903 - 909
  • [9] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [10] A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: Dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely
    Hadac, EM
    Ji, ZS
    Pinon, DI
    Henne, RM
    Lybrand, TP
    Miller, LJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) : 2105 - 2111